Study of Lacutamab in Peripheral T-cell Lymphoma

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(64 sites)

Belgium

Institut Jules Bordet, Anderlecht

VZW ZAS, Antwerp

A. Z. Sint-Jan, Bruges

Cliniques Universitaires de Bruxelles - Hôpital Erasme, Brussels

Cliniques universitaires Saint-Luc - Université catholique de Louvain, Brussels